HRH2 and major depressive disorder: The efficacy of famotidine, a selective histamine H2 receptor antagonist, was tested in a RCT versus placebo, reporting that this drug significantly improved global cognition in the treatment group (N = 25), with no significant correlation with the improvements in depression and anxiety symptoms [42].